Nexilis AG identifies and commercialises research-innovations through selection of feasible applications, technology proofs and defines/clarifies industrial value in order to develop products in the overlapping field between medical devices and biotechnology.
Nexilis AG is building a portfolio balanced between products suitable for licensing to corporate partners and products which are suitable for registration before partnering. Nexilis AG primary focus, however, is to develop products using its proprietary technology through Phase I or II clinical trials. Nexilis AG coordinates and performs the research, preclinical, and clinical activities and partners for later stage clinical trials, registration and manufacturing.
Nexilis AG has experience in establishing product development processes considering quality and regulatory aspects. Nexilis AG is result driven, always seeking practical and realistic solutions. Focus is always to meet the customer’s and partner’s requirements. |
